Abstract Titles and Publications

Abstract Titles

Titles for regular abstracts will be available here on Oct. 5, 2022, and titles for late-breaking abstracts will be available at  Nov. 2, 2022. Once abstract titles are listed on the website, press releases can be issued with the titles and logistical information. Click here for more information on abstract embargo and release information. 

  

Abstract Publications

All accepted abstracts will be available in a Journal for ImmunoTherapy of Cancer (JITC) supplement, which will be published on Nov. 7 at 8 a.m. EST. Full regular and late-breaking abstract content is embargoed until the abstract supplement has published. The link to the abstract supplement will be posted here when available.